Michele Solis is a science writer based in Seattle, WA. She covers brain-related topics for general and scientific audiences alike, and has contributed to many publications, including Scientific American Mind, Nature and Pharmaceutical Journal. Much of her work centers on the biology of mental illness, but other topics have included pain, obesity and robotic surgery.
On June 22, 2019, families of people with DYRK1A syndrome gathered in Seattle to support one another and meet with researchers. A rare condition resulting from mutations to the kinase-encoding gene DYRK1A, the syndrome is associated with anomalous brain development and a range of symptoms, including microcephaly, seizures, speech delay and autism.
On August 2–3, 2019, people from around the world met in Seattle, Washington, to review recent findings about mutations to the sodium channel encoded by SCN2A. Organized by the FamilieSCN2A Foundation, the meeting hosted scientists as well as families of people affected by SCN2A mutations.
On April 18, 2019, SFARI brought together autism specialists and child development experts to explore the short-lived yet critical period of infancy. Understanding how cognition, motor skills and language unfold during the earliest developmental stages of life may help detect autism earlier, parse subtypes and inform mechanistic studies in animal models.